{{Rsnum
|rsid=9326506
|Gene=ZNF239
|Chromosome=10
|position=44068558
|Orientation=plus
|GMAF=0.45
|Gene_s=ZNF239
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 28.6 | 48.2 | 23.2
| HCB | 19.1 | 48.5 | 32.4
| JPT | 15.9 | 52.2 | 31.9
| YRI | 63.9 | 34.0 | 2.0
| ASW | 58.9 | 28.6 | 12.5
| CHB | 19.1 | 48.5 | 32.4
| CHD | 22.1 | 57.7 | 20.2
| GIH | 0.0 | 0.0 | 0.0
| LWK | 71.3 | 25.0 | 3.7
| MEX | 0.0 | 0.0 | 0.0
| MKK | 65.3 | 34.0 | 0.7
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs9326506]] has been reported in a large study to be associated with [[type-2 diabetes]].

The risk allele (oriented to the dbSNP entry) is (C); the odds ratio associated with heterozygotes is 1.28 (CI 1.11-1.48), and for homozygotes, 1.46 (CI 1.24-1.72). {{PMID|17554300|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}